Daniela Cambria
Impact in
-
- Multiple Myeloma Research and Treatments
-
- HIV Research and Treatment
Papers in
-
- Studies on Chitinases and Chitosanases 3
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Lucia Malaguarnera (6 shared papers)Michelino Di Rosa (7 shared papers)Anna Longo (6 shared papers)Maria Concetta Palumbo (5 shared papers)Francesco Di Raimondo (9 shared papers)Francesca Lazzara (3 shared papers)Daniele Tibullo (9 shared papers)Cristina Sanfilippo (3 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Biomarker Research (1 paper)Cancer (1 paper)Scientific Reports (1 paper)Inflammation Research (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Daniela Cambria
15 papers receiving 318 citations
Peers
Comparison fields: 5 of 67
- Hematology 69
- Virology 22
- Immunology 94
- Neurology 32
- Genetics 36
Countries citing papers authored by Daniela Cambria
This map shows the geographic impact of Daniela Cambria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Cambria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Cambria more than expected).
Fields of papers citing papers by Daniela Cambria
This network shows the impact of papers produced by Daniela Cambria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Cambria. The network helps show where Daniela Cambria may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Cambria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 56 | |
| 2 | 2016 | 42 | |
| 3 | 2020 | 42 | |
| 4 | 2020 | 39 | |
| 5 | 2020 | 29 | |
| 6 | 2017 | 27 | |
| 7 | 2015 | 22 | |
| 8 | 2019 | 17 | |
| 9 | 2023 | 13 | |
| 10 | 2017 | 13 | |
| 11 | 2016 | 10 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2025 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2021 | 0 |
About Daniela Cambria
Daniela Cambria is a scholar working on Molecular Biology, Hematology, Infectious Diseases, Virology and Oncology, having authored 16 papers that have together received 321 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), Studies on Chitinases and Chitosanases (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), HIV/AIDS drug development and treatment (2 papers), Invertebrate Immune Response Mechanisms (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Hematology (69 citations), Virology (22 citations), Immunology (94 citations), Neurology (32 citations) and Genetics (36 citations). Daniela Cambria has collaborated with scholars based in Italy and United States. Frequent co-authors include Lucia Malaguarnera, Michelino Di Rosa, Anna Longo, Maria Concetta Palumbo, Francesco Di Raimondo, Francesca Lazzara, Daniele Tibullo, Cristina Sanfilippo, Alessandra Romano and Giuseppe A. Palumbo. Their work appears in journals such as Frontiers in Oncology, Biomarker Research, Cancer, Scientific Reports and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.